No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

Rosey investigators.; Dianne Carey

doi:10.1016/S0140-6736(04)15489-5

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

Rosey investigators., Dianne Carey

UWA Medical School

Research output: Contribution to journal › Article › peer-review

216 Citations (Scopus)

Original language	English
Pages (from-to)	429-438
Number of pages	10
Journal	Lancet
Volume	363
Issue number	9407
DOIs	https://doi.org/10.1016/S0140-6736(04)15489-5
Publication status	Published - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(04)15489-5

Cite this

@article{efe67a2fd2d54acaa50f28cf33fc3fe8,

title = "No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.",

author = "{Rosey investigators.} and Andrew Carr and Cassy Workman and Dianne Carey and Martyn French and Gary Rogers and Allison Martin and David Baker and Handen Wand and Matthew Law and Katherine Samaras and Sean Emery and Cooper, {David A.}",

year = "2004",

doi = "10.1016/S0140-6736(04)15489-5",

language = "English",

volume = " 363",

pages = "429--438",

journal = "Lancet",

issn = "0140-6736",

publisher = "Academic Press",

number = "9407",

}

TY - JOUR

T1 - No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

AU - Rosey investigators.

AU - Carr, Andrew

AU - Workman, Cassy

AU - Carey, Dianne

AU - French, Martyn

AU - Rogers, Gary

AU - Martin, Allison

AU - Baker, David

AU - Wand, Handen

AU - Law, Matthew

AU - Samaras, Katherine

AU - Emery, Sean

AU - Cooper, David A.

PY - 2004

Y1 - 2004

UR - https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)15489-5/fulltext#%20

U2 - 10.1016/S0140-6736(04)15489-5

DO - 10.1016/S0140-6736(04)15489-5

M3 - Article

SN - 0140-6736

VL - 363

SP - 429

EP - 438

JO - Lancet

JF - Lancet

IS - 9407

ER -

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

UN SDGs

Access to Document

Other files and links

Cite this